BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheibani M, Azizi Y, Shayan M, Nezamoleslami S, Eslami F, Farjoo MH, Dehpour AR. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches. Cardiovasc Toxicol. [DOI: 10.1007/s12012-022-09721-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li B, Zhang J, Ma N, Li W, You G, Chen G, Zhao L, Wang Q, Zhou H. PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer. Artif Cells Nanomed Biotechnol 2023;51:120-30. [PMID: 36905212 DOI: 10.1080/21691401.2023.2176865] [Reference Citation Analysis]
2 Yıldızhan K, Huyut Z, Altındağ F. Involvement of TRPM2 Channel on Doxorubicin-Induced Experimental Cardiotoxicity Model: Protective Role of Selenium. Biol Trace Elem Res 2023;201:2458-69. [PMID: 35922740 DOI: 10.1007/s12011-022-03377-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kciuk M, Gielecińska A, Mujwar S, Kołat D, Kałuzińska-Kołat Ż, Celik I, Kontek R. Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells 2023;12. [PMID: 36831326 DOI: 10.3390/cells12040659] [Reference Citation Analysis]
4 Martín-Acosta P, Cuadrado I, González-Cofrade L, Pestano R, Hortelano S, de Las Heras B, Estévez-Braun A. Synthesis of Quinoline and Dihydroquinoline Embelin Derivatives as Cardioprotective Agents. J Nat Prod 2023;86:317-29. [PMID: 36749898 DOI: 10.1021/acs.jnatprod.2c00924] [Reference Citation Analysis]
5 Zhou W, Ouyang J, Hu N, Wang H. Flavonoids from Hippophae rhamnoides Linn. Revert Doxorubicin-Induced Cardiotoxicity through Inhibition of Mitochondrial Dysfunction in H9c2 Cardiomyoblasts In Vitro. Int J Mol Sci 2023;24. [PMID: 36834585 DOI: 10.3390/ijms24043174] [Reference Citation Analysis]
6 Ping Z, Fangfang T, Yuliang Z, Xinyong C, Lang H, Fan H, Jun M, Liang S. Oxidative Stress and Pyroptosis in Doxorubicin-Induced Heart Failure and Atrial Fibrillation. Oxid Med Cell Longev 2023;2023:4938287. [PMID: 36733418 DOI: 10.1155/2023/4938287] [Reference Citation Analysis]
7 Alkhanjaf AAM, Athar MT, Ullah Z, Alsayhab AMH, Umar A, Shaikh IA. Farnesol Protects against Cardiotoxicity Caused by Doxorubicin-Induced Stress, Inflammation, and Cell Death: An In Vivo Study in Wistar Rats. Molecules 2022;27. [PMID: 36500681 DOI: 10.3390/molecules27238589] [Reference Citation Analysis]
8 Bi Y, Xu H, Wang X, Zhu H, Ge J, Ren J, Zhang Y. FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM. Cell Death Dis 2022;13:1020. [PMID: 36470869 DOI: 10.1038/s41419-022-05460-x] [Reference Citation Analysis]
9 Quagliariello V, Basilicata MG, Pepe G, De Anseris R, Di Mauro A, Scognamiglio G, Palma G, Vestuto V, Buccolo S, Luciano A, Barbieri M, Bruzzese F, Maurea C, Pumpo R, Ostacolo C, Campiglia P, Berretta M, Maurea N. Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology? J Cardiovasc Dev Dis 2022;9. [PMID: 36547420 DOI: 10.3390/jcdd9120423] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Khairnar SI, Kulkarni YA, Singh K. Cardiotoxicity linked to anticancer agents and cardioprotective strategy. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01411-4] [Reference Citation Analysis]
11 Shim MK, Yang S, Park J, Yoon JS, Kim J, Moon Y, Shim N, Jo M, Choi Y, Kim K. Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity. J Nanobiotechnology 2022;20:436. [PMID: 36195911 DOI: 10.1186/s12951-022-01644-x] [Reference Citation Analysis]
12 Moro N, Dokshokova L, Perumal Vanaja I, Prando V, Cnudde SJA, Di Bona A, Bariani R, Schirone L, Bauce B, Angelini A, Sciarretta S, Ghigo A, Mongillo M, Zaglia T. Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons. IJMS 2022;23:11098. [DOI: 10.3390/ijms231911098] [Reference Citation Analysis]
13 Hosseini A, Safari MK, Rajabian A, Boroumand-Noughabi S, Eid AH, Al Dhaheri Y, Gumpricht E, Sahebkar A. Cardioprotective Effect of Rheum turkestanicum Against Doxorubicin-Induced Toxicity in Rats. Front Pharmacol 2022;13:909079. [PMID: 35754479 DOI: 10.3389/fphar.2022.909079] [Reference Citation Analysis]
14 Soares NC, Ali A, Srinivasulu V, Sharaf BM, Giddey AD, Okendo J, Al-Hroub HM, Semreen MH, Hamad M, Al-Tel TH. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach. J Proteomics 2022;265:104660. [PMID: 35728772 DOI: 10.1016/j.jprot.2022.104660] [Reference Citation Analysis]
15 Wang X, Zhou Q, Li X, Gan X, Liu P, Feng X, Fang G, Liu Y. Insights into Aptamer-Drug Delivery Systems against Prostate Cancer. Molecules 2022;27:3446. [PMID: 35684384 DOI: 10.3390/molecules27113446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ma X, Gao H, Yang B, Zhao H, Zhu Z. Huaier Polysaccharide Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Regulating Ferroptosis. Bull Exp Biol Med 2022;174:37-42. [PMID: 36437332 DOI: 10.1007/s10517-022-05644-7] [Reference Citation Analysis]